Zhen Cai

机构：Beijing University of Posts and Telecommunications, Key Laboratory of Guangdong Province, Nanfang Hospital, First Affiliated Hospital Zhejiang University, Southern Medical University · ORCID：0000-0002-1602-0052

发表论文 80 篇 · 总被引 300 次 · h-index 10

代表论文

• Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia (2025 · JAMA Oncology · 被引 31)
• LightPROF: A Lightweight Reasoning Framework for Large Language Model on Knowledge Graph (2025 · Proceedings of the AAAI Conference on Artificial Intelligence · 被引 22)
• Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma (2025 · Journal for ImmunoTherapy of Cancer · 被引 17)
• Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma (2025 · Experimental Hematology and Oncology · 被引 4)
• Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group (2025 · Clinical Hematology International · 被引 4)
• Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group (2025 · Clinical Hematology International · 被引 4)